NEW DELHI: India today took a significant step in combating monkeypox with apex drug regulator granting manufacturing licenses for real-time diagnosis to three indigenously developed in vitro kits.
RT-PCR kits for Mpox virus have been developed by three Indian firms in collaboration with the ICMR. The World Health Organisation (WHO) has declared Mpox as a public health emergency of international concern.
The Indian firms are Siemens Healthcare, Transasia Diagnostics and JITM C Genes.